Protocol for 18F-PSMA PET imaging in staging and management of prostate cancer - a retrospective cohort study
Byrne, M. H. V.; Ranasinha, N.; Bryant, R. J.; Hamdy, F. C.; Leslie, T.; Miah, S.; Gleeson, F.; MacPherson, R.; Tuthill, M.; Protheroe, A.; Turner, P.; Sabharwal, A.; Andrade, G.; Lamb, A. D.
Show abstract
BackgroundMRI, bone scan, and CT staging is recommended in the staging of prostate cancer. However, prostate-specific membrane antigen positron emission tomography (PSMA PET) could be superior in detection of local and distant prostate cancer cells. Most PSMA PET scans for prostate cancer are performed with a Gallium-68 ligand, with the Fluorine-18 (18F) ligand being introduced more recently. Methods: We will conduct a retrospective review of electronic patient records for all consecutive patients who underwent preoperative 18F-PSMA PET scan for prostate cancer from its introduction at our centre in 2019. We will compare PET scans with other imaging modalities and evaluate its use in diagnosis and management decisions for prostate cancer. ConclusionsUnderstanding the role of 18F-PSMA PET in diagnosis and management could influence the diagnostic pathway of primary and secondary prostate cancer. Trial registrationNot applicable.
Matching journals
The top 4 journals account for 50% of the predicted probability mass.
Similar papers in this journal
- Protocol summary and statistical analysis plan for the randomized trial of early detection of clinically significant prostate cancer (ProScreen) 92%
- Retrospective Validation of an Artificial Intelligence System for Diagnostic Assessment of Prostate Biopsies on the ProMort Cohort: Study Protocol 92%
- Moving forward through consensus: a national Delphi approach to determine the top research priorities in prostate cancer in Uganda 90%
Similar papers in this journal
- Glycoprofiling of proteins as prostate cancer biomarkers: a multinational population study 93%
- The impact of positive surgical margin parameters and pathological stage on biochemical recurrence after radical prostatectomy: a systematic review and meta-analysis 90%
- Comprehensive analysis of prostate cancer life expectancy, loss of life expectancy, and healthcare expenditures: Taiwan national cohort study spanning 2008 to 2019 89%
Similar papers in this journal
- Volumetric lung cancer screening reduces unnecessary low-dose computed tomography scans: results from a single-centre prospective trial on 4,119 subjects 85%
- The NILS study protocol - a retrospective validation study of a preoperative decision-making tool for non-invasive lymph node staging in women with primary breast cancer [ISRCTN14341750] 84%
- Analytical Validation of MyProstateScore 2.0 84%
Similar papers in this journal
Similar papers in this journal
- Re-irradiation to the Prostate using stereotactic body radiotherapy (SBRT) after initial definitive Radiotherapy – A systematic review and Meta-analysis of recent trials 90%
- Trial protocol: RadTARGET, a multicenter phase II randomized controlled trial evaluating focal radiotherapy boost with de-intensification of dose to non-suspicious prostate in patients with intermediate- or high-risk prostate cancer 90%
- Auto-Detection and Segmentation of Involved Lymph Nodes in HPV-Associated Oropharyngeal Cancer Using a Convolutional Deep Learning Neural Network 87%
"Similar papers" are the closest papers from that journal in the model's embedding space. They show what the match is built on, but the ranking comes mostly from a classifier over the whole training set, not from these examples alone.